Time to check CHEK2 in families with breast cancer?

Journal of Clinical Oncology

Volumn 26, Issue 4, 2008, Pages 519-520

  Offit, Kenneth ^a   Garber, Judy Ellen ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; BRAP PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TUMOR MARKER; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER RISK; EDITORIAL; FAMILY HISTORY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MORBIDITY; POPULATION RESEARCH; PRIORITY JOURNAL; AGED; BREAST TUMOR; DNA REPAIR; ENZYMOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; NOTE;

AGED; BREAST NEOPLASMS; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; PROTEIN-SERINE-THREONINE KINASES; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES;

EID: 39149122546     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.13.8503     Document Type: Editorial

References (24)

1. Bernstein JL, Teraoka SN, John EM, et al: The CHEK2*1100delC allelic variant and risk of breast cancer: Screening results from the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 15:348-352, 2006
2. Tischkowitz M, Xia B, Sabbaghian N, et al: Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 104:6788-6793, 2007
3. Ahmed M, Rahman N: ATM and breast cancer susceptibility. Oncogene 25:5906-5911, 2006
4. Nevanlinna H, Bartek J: The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25:5912-5919, 2006
5. Bell DW, Kim SH, Godwin AK, et al: Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer 121:2661-2667, 2007
6. Weischer M, Bojesen SE, Ellervik C, et al: CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: Meta-analysis of 26,000 patient cases and 27,000 controls. J Clin Oncol 26:542-548, 2008
7. Bell DW, Varley JM, Szydlo TE, et al: Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286:2528-2531, 1999
8. Thompson D, Seal S, Schutte M, et al: A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers. Cancer Epidemiol Biomarkers Prev 15:2542-2545, 2006
9. Chen S, Parmigiani G: Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329-1333, 2007
10. Sodha N, Bullock S, Taylor R, et al: CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours. Br J Cancer 87:1445-1448, 2002
11. Vahteristo P, Bartkova J, Eerola H, et al: A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432-438, 2002
12. Rashid MU, Jakubowksa A, Justenhoven C, et al: German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer. Eur J Cancer 41:2896-2903, 2005
13. Begg CB: On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94:1221-1226, 2002
14. Offit K: BRCA mutation frequency and penetrance: New data, old debate. J Natl Cancer Inst 98:1675-1677, 2006
15. Weischer M, Bojesen SE, Tybjaerg-Hansen A, et al: Increased risk of breast cancer associated with CHEK2*1100delC. J Clin Oncol 25:57-63, 2007
16. CHEK2 Breast Cancer Case-Control Consortium: CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74:1175-1182, 2004
17. Offit K, Pierce H, Kirchhoff T, et al: Frequency of CHEK2* 1100delC in New York breast cancer cases and controls. BMC Med Genet 15:4:1, 2003
18. Friedrichsen DM, Malone KE, Doody DR, et al: Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women. Breast Cancer Res 6:R629-R635, 2004
19. Osorio A, Rodriguez-Lopez R, Diez O, et al: The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer 108:54-56, 2004
20. Rajkumar T, Soumittra N, Nancy NK, et al: BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India. Asian Pac J Cancer Prev 4:203-208, 2003
21. Shaag A, Walsh T, Renbaum P, et al: Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. Hum Mol Genet 14:555-563, 2005
22. Schmidt MK, Tollenaar RA, de Kemp SR, et al: Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2* 1100delC germline mutation. J Clin Oncol 25:64-69, 2007
23. Narod SA, Lynch HT: CHEK2 mutation and hereditary breast cancer. J Clin Oncol 25:6-7, 2007
24. Easton DF, Pooley KA, Dunning AM, et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093, 2007